Submitted
The Trinity Challenge on Antimicrobial Resistance

One Health Genomic surveillance, Antimicrobial access data & free App

Team Leader
Meher Rizvi
Solution & Team Overview
Solution Name:
One Health Genomic surveillance, Antimicrobial access data & free App
Short solution summary:

Genomic surveillance of carbapenem resistant E. coli and K. pneumoniae  isolated from human (pregnant women presenting with UTI), live-stock and sewage to map resistance and virulence across regions and climatic extremes. NGO will educate and collect antimicrobial access data. Film-maker to motivate communities. Stewardship promoted by free mobile application.

In what city, town, or region is your solution team based?
Muscat, Oman
Who is the Team Lead for your solution?

Dr Meher Rizvi, Associate Professor, Sultan Qaboos University,  Principal Investigator, DASH to protect antibiotics https://dashuti.com/, which spans Indian subcontinent, MENA,  Benin, SHEA Ambassador 2021 & ASM Ambassador 22-24,

Which Challenge Objective does your solution most closely address?
  • Innovation
  • Integration
  • Implementation
What specific problem are you solving?

Existing data, including work by our team, indicate LMICs may bear a disproportionately high burden of AMR. However, genomic surveillance of antimicrobial resistance (AMR) and virulence (to assess cost of fitness) in Gram negative bacilli in human, animal and environmental sectors is sparse and fragmented in LMICs making it difficult to understand the scale of the problem, transmission dynamics and identify effective interventions. 

 Estimation of how extremes of temperature and humidity impact AMR across regions is lacking. 

At the policy level, lack of adequate representative data fails to propel effective legislation to curb AMR. At the local level, laboratory data are needed to support  evidence based recommendations which clinical decision support systems (CDSS) can provide. However, most healthcare facilities do not have CDSS or mobile applications. Technology support from HIC are limited.

The potential of NGOs to education to promote healthy behaviour and utilise teachers to collect  data for mapping of  antimicrobial access data are lacking.

Power of narrative driven stories in local languages in catalysing behaviour change remains unexplored. 

 Unless we work in concert on the one health platform, leverage technology, establish meaningful partnerships with the community and interdisciplinary teams in hospitals, AMR will wreak high casualties in LMICs.



Who does your solution serve, and what needs of theirs does it address?

Target groups: Health Care Workers (HCW) in Human and animal healthcare sector, pregnant women attending hospital and PHC ANCs. Communities (adults and children) and antimicrobial access data through teachers (NGOs) and residents (PHCs), local and national governments. 

Support: CRE genomic surveillance in human, animal and environment for mapping resistance. Antimicrobial access data will improve distribution. HCWs through free mobile application. Healthy and informed communities (education through prepared modules), short documentaries (vernacular languages) will catalyze behaviour change, 

Need assessment: Analysis of  questionnaires will provide insight into their knowledge, awareness, practice (KAP) and tailor education. 

Engagement: Education imparted to the community, PHC, doctors and veterinarians is invaluable in responsible antimicrobial prescription and use.  Focused antibiograms, a rarity in LMICs will promote evidence based antimicrobial prescribing. The free Firstline mobile application will sustain the impact by providing a user-friendly and portable resource for healthcare providers.

Inform Policy: Data on antimicrobial access, innovative use of NGOs and PHC staff and collaboration with socially conscious documentary makers will inform new approaches in tackling AMR and gather important data.

Mapping Genomic surveillance of human, animal and environmental origin CRE E. coli and K. pneumoniae will be instrumental in informing policy.

What is your solution’s stage of development?
  • Proof of Concept: A venture or organisation building and testing its prototype, research, product, service, or business/policy model, and has built preliminary evidence or data
More About Your Solution
More About Your Team
Partnership & Growth Opportunities
Solution Team:
Meher Rizvi
Meher Rizvi
Associate Professor
Maria Khan
Maria Khan
Fatima  Khan
Fatima Khan
Jyotsna Agarwal
Jyotsna Agarwal
Hawra Al Lawati
Hawra Al Lawati
Dmytro Stepanskyi
Dmytro Stepanskyi
Aruna Poojary
Aruna Poojary
Reba Kanungo
Reba Kanungo
Nihal Al Riyami
Nihal Al Riyami
Hiba Sami
Hiba Sami
Areena Siddiqui
Areena Siddiqui
Professor
Zaaima ALJabri
Zaaima ALJabri
Assistant professor
Omnia mohamed elnabawy taher
Omnia mohamed elnabawy taher
Dr Mohmed Soeb  Jankhwala
Dr Mohmed Soeb Jankhwala
Sheela Devi Chandrakesan
Sheela Devi Chandrakesan
Dr.Mahfuza Nasrin
Dr.Mahfuza Nasrin